|
|
| (44 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) |
| Zeile 1: |
Zeile 1: |
| | {{pnc}} | | {{pnc}} |
| | + | {{ft|X}} |
| | + | *'''[[Diagnosis (Laboratory other parameters)]]''' |
| | + | *'''[[Dx multi-virus]]''' |
| | + | *'''[[Dx PCR]]''' |
| | + | *'''[[Dx Antigen]]''' |
| | + | *'''[[Dx Antibodies]]''' |
| | + | *'''[[Dx Serology]]''' all the imbecile titles not showing what they intend to test |
| | + | *'''[[Dx Lab. various methods]]''' reviews, n>2 comparisons, intermodality comparisons |
| | + | *'''[[Dx Lab. unconventional methods]]''' |
| | + | *'''[[Dx which matrix]]''' how to obtain, which to use |
| | | | |
| − | | + | ---- |
| − | {{tp|p=32282894|t=ä. Diagnostic Testing for Severe Acute Respiratory Syndrome?Related Coronavirus-2: A Narrative Review |pdf=|usr=}}
| + | |
| − | *[https://archive.fo/61OpY on false-positives]
| + | |
| − | *[https://www.aljazeera.com/news/2020/05/tanzania-covid-19-lab-head-suspended-president-questions-data-200505065136872.html on positives in non-vertebrate samples]
| + | |
| − | *[https://www.wsj.com/articles/roche-coronavirus-antibody-test-wins-fda-approval-for-emergency-use-11588505019 antibody test roche]
| + | |
| − | {{tp|p=32293168|t=ä. Rapid Detection of COVID-19 Causative Virus (SARS-CoV-2) in Human Nasopharyngeal Swab Specimens Using Field-Effect Transistor-Based Biosensor |pdf=|usr=}}
| + | |
| − | {{tp|p=32223179|t=ä. Diagnosing COVID-19: The Disease and Tools for Detection |pdf=|usr=}}
| + | |
| − | {{tp|p=32281785|t=ä. Dual-Functional Plasmonic Photothermal Biosensors for Highly Accurate Severe Acute Respiratory Syndrome Coronavirus 2 Detection |pdf=|usr=}}
| + | |
| − | {{tp|p=32320384|t=2020. Anti-SARS-CoV-2 virus antibody levels in convalescent plasma of six donors who have recovered from COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32304208|t=ä. Assessment of Specimen Pooling to Conserve SARS CoV-2 Testing Resources |pdf=|usr=}}
| + | |
| − | {{tp|p=32227199|t=ä. SARS-CoV-2 Testing: Trials and Tribulations |pdf=|usr=}}
| + | |
| − | {{tp|p=32323974|t=ä. Rapid and Sensitive Detection of anti-SARS-CoV-2 IgG, Using Lanthanide-Doped Nanoparticles-Based Lateral Flow Immunoassay |pdf=|usr=}}
| + | |
| − | {{tp|p=Cä|t=Guidelines for Laboratory Diagnosis of Coronavirus Disease 2019 (COVID-19) in Korea.|pdf=http://europepmc.org/articles/PMC7169629?pdf=render|usr=}}
| + | |
| − | {{tp|p=32259132|t=2020. Laboratory Parameters in Detection of COVID-19 Patients with Positive RT-PCR; a Diagnostic Accuracy Study |pdf=|usr=}}
| + | |
| − | {{tp|p=32331788|t=ä. Case-finding: Fast, Available, and Efficient Font-line Diagnostics for SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | {{tp|p=32290684|t=2020. Exhaled breath condensate as a potential specimen for diagnosing COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32364936|t=2020. Electrochemical biosensors for pathogen detection |pdf=|usr=}}
| + | |
| − | {{tp|p=32330437|t=ä. COVID-19: a meta-analysis of diagnostic test accuracy of commercial assays registered in Brazil |pdf=|usr=}}
| + | |
| − | | + | |
| − | {{tp|p=32360478|t=2020. Emerging key laboratory tests for patients with COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32077933|t=ä. ...Why Partnership between Clinical Laboratories, Public Health Agencies, and Industry Is Essential to Control the Outbreak |pdf=|usr=}}
| + | |
| − | {{tp|p=32154877|t=ä. The SARS-CoV-2 Outbreak: Diagnosis, Infection Prevention, and Public Perception |pdf=|usr=}}
| + | |
| − | {{tp|p=32246822|t=ä. Potential false-negative nucleic acid testing results for Severe Acute Respiratory Syndrome Coronavirus 2 from thermal inactivation of samples with low viral loads |pdf=|usr=}}
| + | |
| − | {{tp|p=32353116|t=ä. Modeling SARS-CoV-2 positivity using laboratory data: timing is everything |pdf=|usr=}}
| + | |
| − | {{tp|p=32343775|t=ä. SARS-CoV-2 Serology: Much Hype, Little Data |pdf=|usr=}}
| + | |
| − | {{tp|p=32315390|t=ä. Rapid detection of COVID-19 coronavirus using a reverse transcriptional loop-mediated isothermal amplification (RT-LAMP) diagnostic platform |pdf=|usr=}}
| + | |
| − | {{tp|p=32282874|t=ä. Limits of Detection of Six Approved RT?PCR Kits for the Novel SARS-coronavirus-2 (SARS-CoV-2) |pdf=|usr=}}
| + | |
| − | {{tp|p=32031590|t=ä. Racing Towards the Development of Diagnostics for a Novel Coronavirus (2019-nCoV) |pdf=|usr=}}
| + | |
| − | {{tp|p=32229107|t=2020. Dynamic change process of target genes by RT-PCR testing of SARS-Cov-2 during the course of a Coronavirus Disease 2019 patient |pdf=|usr=}}
| + | |
| − | {{tp|p=32031583|t=ä. Molecular Diagnosis of a Novel Coronavirus (2019-nCoV) Causing an Outbreak of Pneumonia |pdf=|usr=}}
| + | |
| − | {{tp|p=32156607|t=ä. Positive rate of RT-PCR detection of SARS-CoV-2 infection in 4880 cases from one hospital in Wuhan, China, from Jan to Feb 2020 |pdf=|usr=}}
| + | |
| − | {{tp|p=32343948|t=2020. IgA-Ab response to spike glycoprotein of SARS-CoV-2 in patients with COVID-19: A longitudinal study |pdf=|usr=}}
| + | |
| − | {{tp|p=32335089|t=ä. Highly sensitive detection of SARS-CoV-2 RNA by multiplex rRT-PCR for molecular diagnosis of COVID-19 by clinical laboratories |pdf=|usr=}}
| + | |
| − | {{tp|p=32315614|t=2020. Laboratory data analysis of novel coronavirus (COVID-19) screening in 2510 patients |pdf=|usr=}}
| + | |
| − | {{tp|p=32295319|t=2020. Innovative screening tests for COVID-19 in South Korea |pdf=|usr=}}
| + | |
| − | {{tp|p=32358960|t=ä. Evaluation of COVID-19 RT-qPCR test in multi-sample pools |pdf=|usr=}}
| + | |
| − | {{tp|p=32357209|t=ä. Early detection of SARS-CoV-2 antibodies in COVID-19 patients as a serologic marker of infection |pdf=|usr=}}
| + | |
| − | {{tp|p=32357206|t=ä. Role of serology in the COVID-19 pandemic |pdf=|usr=}}
| + | |
| − | {{tp|p=32221523|t=ä. Quantitative Detection and Viral Load Analysis of SARS-CoV-2 in Infected Patients |pdf=|usr=}}
| + | |
| − | {{tp|p=32221519|t=ä. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019 |pdf=|usr=}}
| + | |
| − | {{tp|p=32047895|t=ä. Consistent Detection of 2019 Novel Coronavirus in Saliva |pdf=|usr=}}
| + | |
| − | {{tp|p=32271374|t=ä. Effect of throat washings on detection of 2019 novel coronavirus |pdf=|usr=}}
| + | |
| − | {{tp|p=32337590|t=ä. Profile of IgG and IgM antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |pdf=|usr=}}
| + | |
| − | {{tp|p=32241023|t=ä. Gargle lavage as a safe and sensitive alternative to swab samples to diagnose COVID-19: a case report in Japan |pdf=|usr=}}
| + | |
| − | {{tp|p=32306047|t=ä. Antibody Detection and Dynamic Characteristics in Patients with COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32306042|t=ä. Testing for SARS-CoV-2: Can We Stop at Two?|pdf=|usr=}}
| + | |
| − | {{tp|p=32276116|t=ä. Rapid and visual detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription loop-mediated isothermal amplification assay |pdf=|usr=}}
| + | |
| − | {{tp|p=32306036|t=ä. Profile of RT-PCR for SARS-CoV-2: a preliminary study from 56 COVID-19 patients |pdf=|usr=}}
| + | |
| − | | + | |
| − | {{tp|p=32326952|t=2020. SARS-CoV-2 viral load in sputum correlates with risk of COVID-19 progression |pdf=|usr=}}
| + | |
| − | {{tp|p=32313785|t=ä. A Review of Salivary Diagnostics and Its Potential Implication in Detection of Covid-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32295707|t=ä. Fast and simple high-throughput testing of COVID 19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32197339|t=2020. Point-of-Care RNA-Based Diagnostic Device for COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32260471|t=2020. In Vitro Diagnostic Assays for COVID-19: Recent Advances and Emerging Trends |pdf=|usr=}}
| + | |
| − | {{tp|p=32316113|t=2020. Combining Point-of-Care Diagnostics and Internet of Medical Things (IoMT) to Combat the COVID-19 Pandemic |pdf=|usr=}}
| + | |
| − | {{tp|p=32244841|t=2020. Blockchain and Artificial Intelligence Technology for Novel Coronavirus Disease-19 Self-Testing |pdf=|usr=}}
| + | |
| − | | + | |
| − | {{tp|p=32267220|t=2020. Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease 2019 Patients |pdf=|usr=}}
| + | |
| − | {{tp|p=32294051|t=2020. Triplex Real-Time RT-PCR for Severe Acute Respiratory Syndrome Coronavirus 2 |pdf=|usr=}}
| + | |
| − | {{tp|p=32273299|t=2020. Self-screening to reduce medical resource consumption facing the COVID-19 pandemic |pdf=|usr=}}
| + | |
| − | {{tp|p=32357808|t=2020. Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients |pdf=|usr=}}
| + | |
| − | {{tp|p=32306864|t=2020. Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patients |pdf=|usr=}}
| + | |
| − | {{tp|p=32196430|t=2020. Laboratory diagnosis of emerging human coronavirus infections - the state of the art |pdf=|usr=}}
| + | |
| − | {{tp|p=32207377|t=2020. Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | {{tp|p=32306853|t=2020. Development of a reverse transcription-loop-mediated isothermal amplification as a rapid early-detection method for novel SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | {{tp|p=32286155|t=2020. Significance of serology testing to assist timely diagnosis of SARS-CoV-2 infections: implication from a family cluster |pdf=|usr=}}
| + | |
| − | {{tp|p=32174267|t=2020. Era of molecular diagnosis for pathogen identification of unexplained pneumonia, lessons to be learned |pdf=|usr=}}
| + | |
| − | {{tp|p=32102625|t=2020. Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity |pdf=|usr=}}
| + | |
| − | {{tp|p=32065057|t=2020. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes |pdf=|usr=}}
| + | |
| − | {{tp|p=32020836|t=2020. RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak |pdf=|usr=}}
| + | |
| − | | + | |
| − | {{tp|p=32270412|t=ä. Ultrarapid diagnosis, microscope imaging, genome sequencing, and culture isolation of SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | {{tp|p=32342252|t=ä. Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards |pdf=|usr=}}
| + | |
| − | {{tp|p=32329811|t=2020. The nucleic acid test of induced sputum should be used for estimation of patients cure with 2019-nCov |pdf=|usr=}}
| + | |
| − | {{tp|p=32156329|t=2020. Evaluation of a quantitative RT-PCR assay for the detection of the emerging coronavirus SARS-CoV-2 using a high throughput system |pdf=|usr=}}
| + | |
| − | {{tp|p=32209163|t=2020. Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020 |pdf=|usr=}}
| + | |
| − | {{tp|p=32156330|t=2020. Rapid establishment of laboratory diagnostics for the novel coronavirus SARS-CoV-2 in Bavaria, Germany, February 2020 |pdf=|usr=}}
| + | |
| − | {{tp|p=31992387|t=2020. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR |pdf=|usr=}}
| + | |
| − | {{tp|p=32046815|t=2020. Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 EU/EEA countries, January 2020 |pdf=|usr=}}
| + | |
| − | {{tp|p=32347204|t=2020. Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020 |pdf=|usr=}}
| + | |
| − | {{tp|p=32290902|t=2020. An alternative workflow for molecular detection of SARS-CoV-2 escape from the NA extraction kit-shortage, Copenhagen, Denmark, March 2020 |pdf=|usr=}}
| + | |
| − | {{tp|p=32290904|t=2020. Roll-out of SARS-CoV-2 testing for healthcare workers at a large NHS Foundation Trust in the United Kingdom, March 2020 |pdf=|usr=}}
| + | |
| − | {{tp|p=32156101|t=2020. Development of a Laboratory-safe and Low-cost Detection Protocol for SARS-CoV-2 of the Coronavirus Disease 2019 (COVID-19) |pdf=|usr=}}
| + | |
| − | {{tp|p=32297805|t=2020. Real-time RT-PCR in COVID-19 detection: issues affecting the results |pdf=|usr=}}
| + | |
| − | | + | |
| − | {{tp|p=32377507|t=ä. A Cautionary Tale of False-Negative Nasopharyngeal COVID-19 Testing |pdf=|usr=}}
| + | |
| − | {{tp|p=32242876|t=2020. Development of in vitro transcribed RNA as positive control for laboratory diagnosis of SARS-CoV-2 in India |pdf=|usr=}}
| + | |
| − | {{tp|p=32342674|t=2020. Glove-Wall System for Respiratory Specimen Collection and COVID-19 Mass Screening |pdf=|usr=}}
| + | |
| − | {{tp|p=32363011|t=2020. Evaluation of a COVID-19 IgM and IgG rapid test; an efficient tool for assessment of past exposure to SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | {{tp|p=32007627|t=2020. Novel coronavirus: From discovery to clinical diagnostics |pdf=|usr=}}
| + | |
| − | {{tp|p=32304994|t=ä. The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients |pdf=|usr=}}
| + | |
| − | {{tp|p=32224986|t=2020. Human Saliva: Non-Invasive Fluid for Detecting Novel Coronavirus (2019-nCoV) |pdf=|usr=}}
| + | |
| − | | + | |
| − | {{tp|p=32371192|t=ä. Using the diagnostic model based on routine laboratory tests to distinguish patients infected with SARS-CoV-2 from those infected with influenza virus |pdf=|usr=}}
| + | |
| − | {{tp|p=32251798|t=2020. Diagnostic value and dynamic variance of serum antibody in coronavirus disease 2019 |pdf=|usr=}}
| + | |
| − | {{tp|p=32344011|t=2020. Mild versus severe COVID-19: Laboratory markers |pdf=|usr=}}
| + | |
| − | {{tp|p=32315809|t=ä. Comparison of nasopharyngeal and oropharyngeal swabs for SARS-CoV-2 detection in 353 patients received tests with both specimens simultaneously |pdf=|usr=}}
| + | |
| − | {{tp|p=32114193|t=2020. Comparison of different samples for 2019 novel coronavirus detection by nucleic acid amplification tests |pdf=|usr=}}
| + | |
| − | {{tp|p=32370065|t=2020. Hybridization Chain Reactions Targeting the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) |pdf=|usr=}}
| + | |
| − | {{tp|p=32344568|t=2020. RT-qPCR Testing of SARS-CoV-2: A Primer |pdf=|usr=}}
| + | |
| − | {{tp|p=32276333|t=2020. Development of a Novel, Genome Subtraction-Derived, SARS-CoV-2-Specific COVID-19-nsp2 Real-Time RT-PCR Assay and Its Evaluation Using Clinical Specimens |pdf=|usr=}}
| + | |
| − | {{tp|p=32325642|t=2020. A Novel Reverse Transcription Loop-Mediated Isothermal Amplification Method for Rapid Detection of SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | | + | |
| − | {{tp|p=32300101|t=2020. Saliva: potential diagnostic value and transmission of 2019-nCoV |pdf=|usr=}}
| + | |
| − | {{tp|p=32286019|t=2020. Serological Assays for SARS-CoV-2 Infectious Disease: Benefits, Limitations and Perspectives |pdf=|usr=}}
| + | |
| − | {{tp|p=32269100|t=2020. Comparative Performance of SARS-CoV-2 Detection Assays using Seven Different Primer/Probe Sets and One Assay Kit |pdf=|usr=}}
| + | |
| − | {{tp|p=32350048|t=2020. Comparison of Commercially Available and Laboratory Developed Assays for in vitro Detection of SARS-CoV-2 in Clinical Laboratories |pdf=|usr=}}
| + | |
| − | {{tp|p=32350047|t=2020. The Role of Antibody Testing for SARS-CoV-2: Is There One?|pdf=|usr=}}
| + | |
| − | {{tp|p=32341143|t=2020. Comparison of Four Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2 in Nasopharyngeal Specimens |pdf=|usr=}}
| + | |
| − | {{tp|p=32341142|t=2020. Evaluation of the QIAstat-Dx Respiratory SARS-CoV-2 Panel, the first rapid multiplex PCR commercial assay for SARS-CoV-2 detection |pdf=|usr=}}
| + | |
| − | {{tp|p=32341141|t=2020. Evaluation of Transport Media and Specimen Transport Conditions for the Detection of SARS-CoV-2 Using Real Time Reverse Transcription PCR |pdf=|usr=}}
| + | |
| − | {{tp|p=32332061|t=2020. Clinical Evaluation of Three Sample-To-Answer Platforms for the Detection of SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | {{tp|p=32327448|t=2020. Comparison of Abbott ID Now and Abbott m2000 methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from symptomatic patients |pdf=|usr=}}
| + | |
| − | {{tp|p=32132196|t=2020. Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated In Vitro and with Clinical Specimens |pdf=|usr=}}
| + | |
| − | {{tp|p=32102856|t=2020. Negative Nasopharyngeal and Oropharyngeal Swabs Do Not Rule Out COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32317257|t=2020. Saliva as a non-invasive specimen for detection of SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | {{tp|p=32317256|t=2020. Validation of the Hologic s Aptima Unisex and Multitest Specimen collection kits used for Endocervical and Male Urethral Swab Specimen (Aptima Swab) for sample collection of SARS-CoV-2 |pdf=|usr=}}
| + | |
| − | {{tp|p=32303565|t=2020. The Detection of SARS-CoV-2 using the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays |pdf=|usr=}}
| + | |
| − | {{tp|p=32303564|t=2020. Comparison of Abbott ID Now, Diasorin Simplexa, and CDC FDA EUA methods for the detection of SARS-CoV-2 from nasopharyngeal and nasal swabs from individuals diagnosed with COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=32295896|t=2020. Nasal swab sampling for SARS-CoV-2: A convenient alternative in time of nasopharyngeal swab shortage |pdf=|usr=}}
| + | |
| − | {{tp|p=32277023|t=2020. A method to prevent SARS-CoV-2 IgM false positives in gold immunochromatography and enzyme-linked immunosorbent assays |pdf=|usr=}}
| + | |
| − | {{tp|p=32277022|t=2020. Clinical evaluation of the cobas SARS-CoV-2 test and a diagnostic platform switch during 48 hours in the midst of the COVID-19 pandemic |pdf=|usr=}}
| + | |
| − | {{tp|p=32361322|t=2020. Interpret with caution: An evaluation of the commercial AusDiagnostics versus in-house developed assays for the detection of SARS-CoV-2 virus |pdf=|usr=}}
| + | |
| − | {{tp|p=32361324|t=ä. Dynamic profile of RT-PCR findings from 301 COVID-19 patients in Wuhan, China: a descriptive study |pdf=|usr=}}
| + | |
| − | {{tp|p=32302956|t=2020. Consistency analysis of COVID-19 nucleic acid tests and the changes of lung CT |pdf=|usr=}}
| + | |
| − | {{tp|p=32328218|t=ä. Salivary diagnostics in COVID-19: Future research implications |pdf=|usr=}}
| + | |
| − | | + | |
| − | {{tp|p=32209385|t=ä. Profile of specific antibodies to SARS-CoV-2: The first report |pdf=|usr=}}
| + | |
| − | {{tp|p=32360885|t=ä. Value and Challenges: Nucleic Acid Amplification Tests for SARS?CoV-2 in Hospitalized COVID-19 Patients |pdf=|usr=}}
| + | |
| − | {{tp|p=32335175|t=ä. Reliability and usefulness of a rapid IgM?IgG antibody test for the diagnosis of SARS-CoV-2 infection: a preliminary report |pdf=|usr=}}
| + | |
| − | {{tp|p=32335168|t=ä. Dynamics of anti-SARS-Cov-2 IgM and IgG antibodies among COVID-19 patients |pdf=|usr=}}
| + | |
| − | {{tp|p=32298676|t=ä. Saliva is a reliable tool to detect SARS-CoV-2 |pdf=|usr=}}
| + | |
